Utilization of the ketogenic diet for adults with status epilepticus
Epilepsy & Behavior · 2023
DOI: 10.1016/j.yebeh.2023.109279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2023. Verfasst von Fernanda J P Teixeira und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Division of Neurocritical Care, University of Florida College of Medicine, Gainesville, FL 32611, USA; Department of Neurolo…. Hauptthemen laut MEDLINE: Diet, Ketogenic, Status Epilepticus, Epilepsy, Ketosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Academy of Nutrition and Dietetics, American Epilepsy Society, American Academy of Neurology.
Abstract (Originalsprache)
BACKGROUND: The ketogenic diet (KD) is a high-fat, low-carbohydrate diet with therapeutic potential in refractory seizures, both in outpatient and inpatient settings. Successful implementation of KD involves a multifaceted, interdisciplinary approach to address anticipated challenges. We sought to characterize the utilization of KD among healthcare providers caring for adults with status epilepticus (SE). METHODS: We distributed a web-based survey through professional societies, including the American Academy of Neurology (AAN), Neurocritical Care Society (NCS), American Epilepsy Society (AES), Neuro Anesthesia and Critical Care Society (NACCS), and the Academy of Nutrition and Dietetics (AND), and via research contacts. We asked respondents about practice experience and experience using KD as a treatment for SE. Descriptive statistics and Chi-square tests were used to analyze the results. RESULTS: Of 156 respondents, 80% of physicians and 18% of non-physicians reported experience with KD for SE. Anticipated difficulty in achieving ketosis (36.3%), lack of expertise (24.2%), and lack of resources (20.9%) were identified as the most important barriers limiting the utilization of KD. The absence of dietitians (37.1%) or pharmacists (25.7%) support was the most important missing resource. Reasons for stopping KD included perceived ineffectiveness (29.1%), difficulty achieving ketosis (24.6%), and side effects (17.3%). Academic centers had more experience with the use of KD and greater EEG monitoring availability and fewer barriers to its implementation. The need for randomized clinical trials supporting efficacy (36.5%) and better practice guidelines for implementation and maintenance of KD (29.6%) were cited most frequently as factors to increase utilization of KD. CONCLUSION: This study identifies important barriers to the utilization of KD as a treatment for SE despite evidence supporting its efficacy in the appropriate clinical context, namely lack of resources and interdisciplinary support, and lack of established practice guidelines. Our results highlight the need for future research to improve understanding of the efficacy and safety of KD along with better interdisciplinary collaborations to increase its utilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Division of Neurocritical Care, University of Florida College of Medicine, Gainesville, FL 32611, USA; Department of Neurology, University of Miami, Miami, FL 33136, USA.
- State University of New York College of Optometry, New York, NY 10036, USA.
- Department of Neurology, Division of Neurocritical Care, University of Florida College of Medicine, Gainesville, FL 32611, USA; Department of Neurosurgery, University of Florida, College of Medicine, Gainesville, FL 326…
- Department of Neurology, Division of Neurocritical Care, University of Florida College of Medicine, Gainesville, FL 32611, USA.
- Department of Biostatistics, University of Florida, Gainesville, FL 32611, USA.
- University of Florida Health Shands Hospital, Gainesville, FL 32610, USA.
Förderung
- Academy of Nutrition and Dietetics
- American Epilepsy Society
- American Academy of Neurology
- Neurocritical Care Society
Zitieren
APA
Teixeira, F. J. P., Shannon, J., Busl, K. M., Robinson, C. P., Ahmed, B., Katz, J., Miao, G., Seckar, J., Bruzzone, M., Cervenka, M. C., & Maciel, C. B. (2023). Utilization of the ketogenic diet for adults with status epilepticus. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2023.109279
Vancouver
Teixeira FJP, Shannon J, Busl KM, Robinson CP, Ahmed B, Katz J, et al. Utilization of the ketogenic diet for adults with status epilepticus. Epilepsy & Behavior. 2023. doi:10.1016/j.yebeh.2023.109279
BibTeX
@article{Teixeira2023,
author = {Teixeira, Fernanda J P and Shannon, Jacqueline and Busl, Katharina M and Robinson, Christopher P and Ahmed, Bakhtawar and Katz, Jason and Miao, Guanhong and Seckar, Jenna and Bruzzone, Maria and Cervenka, Mackenzie C and Maciel, Carolina B},
title = {Utilization of the ketogenic diet for adults with status epilepticus},
journal = {Epilepsy & Behavior},
year = {2023},
doi = {10.1016/j.yebeh.2023.109279}
}
EUVIMED